These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9344222)

  • 1. Long-term low-dose cyclosporine therapy for psoriasis.
    Campbell JL; Zug KA
    J Am Acad Dermatol; 1997 Oct; 37(4):671-2. PubMed ID: 9344222
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure.
    Lowe NJ; Wieder JM; Rosenbach A; Johnson K; Kunkel R; Bainbridge C; Bourget T; Dimov I; Simpson K; Glass E; Grabie MT
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):710-9. PubMed ID: 8912566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function after 10 years' treatment with cyclosporin for psoriasis.
    Powles AV; Hardman CM; Porter WM; Cook T; Hulme B; Fry L
    Br J Dermatol; 1998 Mar; 138(3):443-9. PubMed ID: 9580797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up study.
    Isnard Bagnis C; Tezenas du Montcel S; Beaufils H; Jouanneau C; Jaudon MC; Maksud P; Mallet A; LeHoang P; Deray G
    J Am Soc Nephrol; 2002 Dec; 13(12):2962-8. PubMed ID: 12444215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can maintenance cyclosporine be used in psoriasis without decreasing renal function?
    Silverman AK; Emmett M; Menter A
    Semin Dermatol; 1992 Dec; 11(4):302-12. PubMed ID: 1493094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis: immunopathology and long-term treatment with cyclosporin.
    Fry L
    J Autoimmun; 1992 Apr; 5 Suppl A():277-83. PubMed ID: 1503622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiating Neoral therapy.
    Lowe NJ
    Int J Dermatol; 1997 Dec; 36 Suppl 1():30-3. PubMed ID: 9466219
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective study of renal structure and function in psoriasis patients treated with cyclosporin.
    Young EW; Ellis CN; Messana JM; Johnson KJ; Leichtman AB; Mihatsch MJ; Hamilton TA; Groisser DS; Fradin MS; Voorhees JJ
    Kidney Int; 1994 Oct; 46(4):1216-22. PubMed ID: 7861719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term renal function in heart transplant recipients receiving cyclosporine therapy.
    Goral S; Ynares C; Shyr Y; Yeoh TK; Johnson HK
    J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic renal changes during cyclosporine treatment of psoriasis. Studies on pretreatment and posttreatment kidney biopsy specimens.
    Zachariae H; Hansen HE; Kragballe K; Olsen S
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):415-9. PubMed ID: 1564147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal biopsy in connection with long-term treatment of psoriasis with cyclosporine].
    Zachariae H; Kragballe K; Hansen HE; Marcussen N; Olsen S
    Ugeskr Laeger; 1998 Jul; 160(31):4534-8. PubMed ID: 9700311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety of cyclosporine in the treatment of psoriasis.
    Grossman RM; Chevret S; Abi-Rached J; Blanchet F; Dubertret L
    Arch Dermatol; 1996 Jun; 132(6):623-9. PubMed ID: 8651712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
    Neumayer HH; Färber L; Budde K; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Transplant Proc; 1996 Aug; 28(4):2207-13. PubMed ID: 8769202
    [No Abstract]   [Full Text] [Related]  

  • 14. Does everolimus associated with a low dose of cyclosporine in long-term cardiac transplant recipients improve renal function? Initial experience.
    Boffini M; Sansone F; Patanè F; Bonato R; Ribezzo M; Iacovino C; Comoglio C; Rinaldi M
    Transplant Proc; 2009 May; 41(4):1349-52. PubMed ID: 19460557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine: what clinicians need to know.
    Koo J; Lee J
    Dermatol Clin; 1995 Oct; 13(4):897-907. PubMed ID: 8785893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal function during long-term cyclosporin treatment of psoriasis].
    Kaoukhov A; Paul C; Lahfa M; Blanchet F; Dubertret L
    Ann Dermatol Venereol; 2000 Feb; 127(2):180-3. PubMed ID: 10739977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice.
    Hong JR; Lee YW; Choe YB; Ahn KJ
    Dermatol Ther; 2019 May; 32(3):e12875. PubMed ID: 30884082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporine.
    Pei Y; Scholey JW; Katz A; Schachter R; Murphy GF; Cattran D
    Am J Kidney Dis; 1994 Apr; 23(4):528-36. PubMed ID: 8154488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine A in the treatment of psoriasis: a clinical and mechanistic perspective.
    Griffiths CE; Voorhees JJ
    J Invest Dermatol; 1990 Nov; 95(5 Suppl):53S-55S. PubMed ID: 16788634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclosporine and severe psoriasis].
    Mazer JM
    Ann Dermatol Venereol; 1996; 123(4):280-4. PubMed ID: 8763757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.